Bareza Rezaei

Bareza Rezaei

Auto-generated profile, based on publicly available information

Bareza Rezaei

Department of Emergency Medicine, Faculty of Medicine, Clinical Research Development Center of Taleghani, Kermanshah University of Medical Sciences, Kermanshah, Iran

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2013 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
MAMostafa Alavi-Moghaddam
Mostafa Alavi-Moghaddam
HBHooman Bakhshi
Hooman Bakhshi
BRBareza Rezaei
Bareza Rezaei
PKPatricia Khashayar
Patricia Khashayar
To compare the prognostic value of the pneumonia severity index and the severity score for community-acquired pneumonia (CURB-65) in predicting mortality and the need for ICU admission of patients with community-acquired pneumonia referred to our emergency department. This prospective study was performed on patients with community-acquired pneumonia admitted to the emergency department of Imam Hossein Medical Center, Tehran, Iran. A questionnaire with demographic information, clinical signs and symptoms, laboratory and radiographic findings was completed for each patient. The information required for calculating the pneumonia severity index and CURB-65 were extracted from the medical records. The patients' clinical outcome was also recorded within a month after admission. We studied 200 patients with community-acquired pneumonia (122 men, 78 women). The sensitivity and specificity of CURB-65 in predicting mortality were 100% and 82.3%, respectively. As for pneumonia severity index, the rates were 100% and 75%, respectively. The sensitivity and specificity rates of CURB-65 and pneumonia severity index in predicting mortality and need for ICU admission were 96.7% and 89.3%, and 90% and 78.7%, respectively. CURB-65 seems to be the preferred method to predict mortality and need for ICU admission in patients with community-acquired pneumonia. Despite their comparable specificity and sensitivity, CURB-65 is much easier to implement.

1 December 2021 in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
GMGhafar-Ali Mahmoudi
Ghafar-Ali Mahmoudi
MAMaryam Ahadi
Maryam Ahadi
AFAli Fouladvand
Ali Fouladvand
BRBareza Rezaei
Bareza Rezaei
ZBZahra Bodagh
Zahra Bodagh
PAPeyman Astaraki
Peyman Astaraki
Background:Antivenom is a gold-standard treatment for snakebite envenoming. However, adverse reactions to snake antivenom are common in many parts. Objective:The aim of this study was to evaluate the allergic reactions following intravenous administration of antivenom sera. Methods:This was retrospective study, conducted snakebites patients referred to the Rahimi Hospital in Khorramabad. The files of these patients were accessed for demographic data, snakebite-related data, treatment provided, clinical presentation and allergic reaction status as a result of antivenom treatment. Results:141 cases were investigated including 73.8% male and 26.2% female patients. The mean age of the patients was 38.1±17.1years. Age group 30-39 years accounted for highest number of snakebite cases (24.1%). A majority of victims (89.4%) were from the rural areas. Most of the patients (51.8%) were bitten in the spring and highest number of snakebite were reported in May (39.1%). The most common site of snakebite was lower extremities (50.4%) and upper extremities (44.7%). Among clinical feature of snakebite, pain was the most prevalent in 135 cases (95.7%) followed by swelling (83.7%). The mean antivenom vials used were 6.5±3.7 vials. Allergic reactions occurred in 6 patients (4.26%); reactions were mild in 5 patients and sever in 1patient. The commonest presentation was maculopapular rash (1.4%) and the least common were headache (0.71%), nausea (0.71%), fever (0.71) and hypotension (0.71%). Conclusion:Snakebite is one of the significantlife-threatening environmental events.Immediate antivenom treatment can reduce mortality however, patients should be carefully monitored for adverse allergic reactions.

4 July 2023 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
MGMohammad Hesam Gharaeikhezri
Mohammad Hesam Gharaeikhezri
FFFarinaz Fattahi
Farinaz Fattahi
PKPegah Karami
Pegah Karami
AGArash Izadpanah Ghahremani
Arash Izadpanah Ghahremani
BRBareza Rezaei
Bareza Rezaei
MRMohammad Reza Rezaei
Mohammad Reza Rezaei
Introduction: Methanol intoxication and subsequence acute kidney injury (AKI) can be dangerous and deadly in case of a missed or delayed diagnosis; therefore, identifying its prevalence and predictor factors is necessary. Objectives: This study was conducted to identify the prevalence and predictor factors of AKI in methyl alcohol-intoxicated patients. Methods and Materials: The search strategy was conducted with the standard keyword in the international database, including Web of Science, Scopus, PubMed /Medline, Embase, Cochrane, WorldCat, Dimension, OpenGrey, EBSCO, DOAJ, CINAHL, and Google scholar search engines. Studies that reported the prevalence of AKI due to methanol poisoning were included in this review study. Results: Results demonstrated that six studies from five countries, with a sample size of 816 methanol intoxication patients, were included in this study. Mean AKI prevalence in all reviewed studies was 28.18%; Gender male, hypertension, older age, anemia, alcohol addiction, metabolic acidosis, high blood osmolality, high Formate concentration, alcohol overdose, sepsis, rhabdomyolysis, acute pancreatitis, and volume depletion were the reported AKI predictors in the reviewed studies. Conclusion: Identifying the AKI prevalence and its predictor factors in patients with methanol intoxication can help in their quick diagnosis, timely treatment, and reduce the subsequent complications.

1 January 2023 in Journal of Renal Endocrinology
Verified
Journal Article
Open access
PDF file
FFFarinaz Fattahi
Farinaz Fattahi
MFMohammad Reza Farnia
Mohammad Reza Farnia
BRBareza Rezaei
Bareza Rezaei
HRHooman Rafiei
Hooman Rafiei
AOAisan Ghasemi Oskui
Aisan Ghasemi Oskui
MRMohammad Reza Rezaei
Mohammad Reza Rezaei
Introduction: Kidney dysfunction, coagulopathy disorders, and lung involvement are the most common disorders caused by the COVID-19 virus. Objectives: This study aimed to investigate the correlation of lung involvement severity with kidney dysfunction and coagulopathy disorders in COVID-19 patients. Patients and Methods: This descriptive-analytical study was conducted on 97 patients with COVID-19 referred to Imam Reza hospital in Kermanshah from December 2020 to June 2021. Lung involvement severity, kidney function tests, and coagulation laboratory data were collected. Logistic regression test was conducted to explore the correlation between lung involvement with kidney dysfunction and coagulopathy disorders. Results: Out of 97 patients, 53 (54.6%) were male, with a mean age of 59.31 ± 16.44 years. The correlation between lung involvement severity with kidney function tests, including, blood urea nitrogen, serum creatinine, and coagulation factors, including prothrombin time (PT), partial thromboplastin time (PTT), and D-dimer, were significant (P > 0.05). Lung involvement severity significantly predicted kidney dysfunction and coagulopathy disorders. Conclusion: Lung involvement severity would be able to predict kidney dysfunction and coagulopathy disorders in patients with COVID-19.

16 May 2023 in Journal of Nephropharmacology
Verified
Journal Article
Open access
PDF file
MRMohammad Reza Rezaei
Mohammad Reza Rezaei
MKMohamad Khaledi
Mohamad Khaledi
BRBareza Rezaei
Bareza Rezaei
MFMohammad Reza Farnia
Mohammad Reza Farnia
HRHooman Rafiei
Hooman Rafiei
FFFarinaz Fattahi
Farinaz Fattahi
Introduction: Acute kidney injury (AKI) is a prevalent clinical syndrome in hospitalized patients associated with uric acid levels in patients. This study aims to evaluate the relationship between hyperuricemia and the risk of AKI using a systematic review and meta-analysis approach. Materials and Methods: This systematic review and meta-analysis was performed based on PRISMA guidelines. A query on international databases, including Cochrane, Web of Science, PubMed, Scopus, and the Google Scholar search engine, was conducted using relevant keywords. The literature search stage was updated until January 2023. Data were analyzed in STATA 14 software. A significance level of P < 0.05 was considered for all tests. Results: A total of 22 articles published from 2006 to 2023 with a sample size of 82469 patients were reviewed. The estimated odds ratio (OR) was 1.96 (95% CI: 1.63, 2.35, P=0.000, I2=89.6%) between hyperuricemia and the risk of AKI and 1.64 (OR: 1.64; 95% CI: 1.23, 2.20, P=0.012, I2=63.2%) between hyperuricemia and AKI mortality and these relationships were statistically significant. In addition, the OR of hyperuricemia and AKI was 1.96 (95% CI: 0.97, 3.98, P=0.000, I2=97.9%) in males and 2.34 (OR: 2.34; 95% CI: 1.14, 4.78, P=0.000, I2=97.9%) in females. The OR of hyperuricemia and AKI was 1.07 (95% CI: 1.03, 1.10) in 30-39 years, 2.37 (95% CI: 1.04, 5.42) in 40-49 years, 4.71 (95% CI: 1.29, 17.20) in 50-59 years, 2.07 (95% CI: 1.58, 2.71) in 60-69 years, and 1.42 (95% CI: 1.04, 1.93) in 70-79 years age groups. Conclusion: Hyperuricemia significantly increases the risk of AKI and mortality. Therefore, by reducing the serum level of uric acid, the risks caused by it can be avoided. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO website (ID: CRD42023393648).

25 October 2025 in Journal of Preventive Epidemiology
Verified
Journal Article
Closed access
MRMohammad Reza Rezaei
Mohammad Reza Rezaei
MFMohammad Reza Farnia
Mohammad Reza Farnia
STShahrouz Tabrizi
Shahrouz Tabrizi
AOAisan Ghasemi Oskui
Aisan Ghasemi Oskui
MSMaryam Shiravand
Maryam Shiravand
BRBareza Rezaei
Bareza Rezaei
Introduction: The diagnosis of thoracic bone fractures in patients with chest trauma is a critical area of study, particularly in emergency medicine. Clinical findings and examinations play a significant role in accurately diagnosing these injuries, which can lead to improved patient outcomes. Objectives: This investigation focuses on the predictive power of various clinical indicators and examination techniques used in diagnosing thorax bone fractures among patients referred to Taleghani hospital in Kermanshah, Iran, from April 2022 to November 2024. Patients and Methods: This retrospective cross-sectional study was conducted to assess the predictive power of clinical findings and examinations in diagnosing thorax bone fractures among patients with chest trauma at Taleghani hospital from April 2022 to November 2024. Data were collected from clinical documents, including demographic information, clinical findings, and imaging studies (X-rays, ultrasounds, and CT scans), focusing on patients aged 18 and older. Logistic regression was conducted to evaluate the correlations between clinical indicators and bone fracture diagnoses. Results: The study included 997 chest trauma patients with a mean age of 43.02 ± 16.7 years, of whom 114 (11.4%) were found to have thoracic bone fractures. Age was identified as an independent predictor for thorax bone fracture, with an OR of 1.02, and hemothorax and pneumothorax demonstrated a strong association, with an OR of 6.25 and 5.40. Similarly, patients with a pain score ≥ 5 were found to be 5.18 times more likely to experience bone fractures compared to less than five. Additionally, pulmonary sound loss (OR = 3.86), pulmonary contusion (OR = 5.28), and subcutaneous crepitation (OR = 3.49) were notable predictors of fractures. Conclusion: In conclusion, age, hemothorax, pneumothorax, a pain score of 5 or higher, along with pulmonary sound loss, pulmonary contusion, and subcutaneous crepitation are significant predictors of thorax bone fractures and enhance the predictive model for identifying at-risk patients in chest trauma cases.